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Abstract: Epidemiologic studies support the premise that Allium vegetables may lower the risk 
of cancers. The beneﬁ  cial effects appear related to the organosulfur products generated upon 
processing of Allium. Leukemia cells from patients with acute myeloid leukemia (AML) display 
high proliferative capacity and have a reduced capacity of undergoing apoptosis and maturation. 
Whether the sulfur-containing molecules thiosulﬁ  nates (TS), diallyl TS (All2TS), dipropyl TS 
(Pr2TS) and dimethyl TS (Me2TS), are able to exert chemopreventative activity against AML 
is presently unknown. The present study was an evaluation of proliferation, cytotoxicity, 
differentiation and secretion of AML cell lines (U937, NB4, HL-60, MonoMac-6) in response 
to treatment with these TS and their related sulﬁ  des (diallylsulﬁ  de, diallyl disulﬁ  de, dipropyl 
disulﬁ  de, dimethyl disulﬁ  de). As assessed by ﬂ  ow cytometry, ELISA, gelatin zymogaphy 
and RT-PCR, we showed that Pr2TS and Me2TS, but not All2TS and sulﬁ  des, 1) inhibited 
cell proliferation in dose- and time-dependent manner and this process was neither due to 
cytotoxicity nor apoptosis, 2) induced macrophage maturation, and 3) inhibited the levels of 
secreted MMP-9 (protein and activity) and TNF-α protein, without altering mRNA levels. By 
establishing for the ﬁ  rst time that Pr2TS and Me2TS affect proliferation, differentiation and 
secretion of leukemic cell lines, this study provides the opportunity to explore the potential 
efﬁ  ciency of these molecules in AML.
Keywords: acute myeloid leukemia, thiosulﬁ  nate, proliferation, differentiation, matrix 
metalloproteinase-9
Introduction
Acute myeloid leukemia (AML) is a deadly disease, resulting from the clonal expansion 
and accumulation of hematopoietic stem cells arrested at various stages of development 
(Mason et al 2006; Plesa et al 2008). Leukemia cells are unable to undergo growth 
arrest, terminal differentiation and apoptosis in response to appropriate environmental 
stimuli, and prematurely egress from the bone marrow to disseminate into peripheral 
tissues (Mason et al 2006; Plesa et al 2008). The standard approach to AML remains 
chemotherapy, and the novel agents currently available (multidrug resistance 
inhibitors, farnesyltransferase inhibitors, receptor kinase inhibitors, monoclonal 
CD33 antibody-mediated drugs) (King et al 2007; Thomas et al 2007) show some 
efﬁ  cacy in either monotherapy or in combination with conventional chemotherapeutic 
drugs such as anthracycline, cytarabine or idarubicin (Adachi et al 2004; Leone et al 
2006; Thomas et al 2007). The development of new compounds directed against 
leukemia-speciﬁ  c targets is however needed to increase the cure rate in AML patients 
exhibiting chemoresistance and poor outcomes.
Allium vegetables (including garlic, onions, leeks, chives, and scallions) are used 
throughout the world for their sensory characteristics as well as their apparent health 
beneﬁ  ts (Amagase 2006; Borek 2006; Milner 2006). They exhibit antimicrobial, Biologics: Targets & Therapy 2008:2(4) 886
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antithrombotic, antitumor, antiarthritic and hypoglycemic 
properties (Ackermann et al 2001; Pinto et al 2001; Khanum 
et al 2004; Amagase 2006; Borek 2006; Milner 2006) which 
are largely attributed to the presence of sulfur compounds in 
these plants (Le Bon et al 2000; Lanzotti 2006). For example, 
the major sulfur-containing molecules in intact garlic are 
sulfoxides, which are converted into thiosulﬁ  nates (such as 
Allicin) when raw garlic is cut or crushed (Amagase 2006; 
Lanzotti 2006). Allicin (diallyl thiosulﬁ  nate/All2TS) (Figure 
1) is rapidly decomposed to diallyldisulﬁ  de (DADS) (Figure 
1), diallylsulﬁ  de (DAS) (Figure 1), diallyltrisulﬁ  de (DATS) 
(Figure 1) and sulfur dioxide, and therefore does not seem 
to be a genuine active compound of garlic (Amagase 2006). 
DADS and DATS exert antiproliferative and proapoptotic 
effects in human epithelial cancer and neuronal cell lines 
(Sundaram et al 1996b; Pinto et al 2001; Hosono et al 2005; 
Milner 2006; Xiao et al 2005, 2006). DADS induces apop-
tosis in the leukemic HL-60 cell line through activation of 
caspase-3 (Kwon et al 2002), and inhibits NO synthesis in 
LPS-activated macrophages (Ippoushi et al 2002). DATS 
also stimulates apoptosis of HL-60 cells (Zheng et al 
1997) and inhibits platelet function by inhibiting platelet 
aggregation and Ca(2+) mobilization (Qi et al 2000). 
Other thiosulﬁ  nates such as dipropyl thiosulﬁ  nate (Pr2TS) 
and dimethyl thiosulﬁ  nate (Me2TS) (Figure 1) are mainly 
identiﬁ  ed in onion and leek (Lanzotti 2006). Pr2TS, Me2TS 
and All2TS are found to inhibit platelet aggregation through 
inhibition of calpain (Rendu et al 2001), by reaction with 
surface free sulfhydryls and internal thiol-containing proteins 
(Badol et al 2007).
Whether Pr2TS, Me2TS and All2TS are able to exert 
chemopreventative activity against AML is presently 
unknown. With the above in mind, we undertook this 
study to evaluate the in vitro efﬁ  cacy of these compounds 
on human cell lines representative of AML. We show that 
Pr2TS and Me2Ts, but not All2TS and their related sulﬁ  des, 
inhibit the growth of AML cell lines and interfere with the 
secretion of tumor necrosis factor-α (TNF-α) and matrix 
metalloproteinase-9 (MMP-9). Additional studies are 
warranted to investigate the inhibitory activity of Pr2TS and 
Me2TS in AML patients’ cells ex vivo.
Materials and methods
Chemicals and antibodies
Monoclonal antibodies (mAbs) (ﬂ  uorescein isothiocyanate, 
FITC; phycoerythrin, PE) specific for CD11b (mIgG1, 
BEAR1), CD13 (mIgG1, SJ1D1), CD15 (mIgM, 80H5), 
CD44 (mIgG1, J-173), Apo 2.7 (mIgG1, 27AGA3), 
their isotypes and the Annexin V-FITC staining kit were 
obtained from Coulter/Beckman (Luminy, France). Irrel-
evant mouse (m)IgGs (FITC and PE) were obtained from 
R&D (Adbington, UK). Phorbol myristate acetate (PMA), 
nigericin, dimethyl disulﬁ  de (DMDS), dipropyl disulﬁ  de 
(DPDS), diallylsulﬁ  de (DAS), and diallyl disulﬁ  de (DADS) 
were obtained from Sigma-Aldrich (Saint Louis, MO, USA). 
Diallyl thiosulﬁ  nate (All2TS), dipropyl thiosulﬁ  nate (Pr2TS) 
and dimethyl thiosulﬁ  nate (Me2TS) were synthesized as 
previously described (Auger et al 1990). Organosulfur-
compounds were solubilized in water. The stability of TS 
was assessed by HPLC analysis (Arnault et al 2003). All-
trans retinoic acid was provided by Ares-Serono (Geneva, 
Switzerland).
Human AML cell lines and cell culture
Models of AML were represented by U937 cell line 
(monoblastic stage, AML-M5) (Ferrara et al 2001) 
(American Tissue Cell Culture), HL-60 cell line (promy-
elocytic stage, AML-M2) (Drexler et al 1999) (American 
Tissue Cell Culture), NB4 cell line (promyelocytic stage, 
AML-M3) (Lanotte et al 1991) (a gift from Dr Lanotte, 
Hôpital Saint Louis, Paris, France) and MonoMac-6 
(promonocytic stage, AML-M5) (Drexler et al 2004) 
(a gift from Dr Ziegler-Heitbrock, University of Munich, 
Germany). Cells were maintained in RPMI 1640 medium 
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supplemented with 5% heat-inactivated fetal calf serum 
(FCS; Gibco, Paisley, Scotland, LPS levels  0.1 ng/mL), 
2 mM L-glutamine, 1 mM sodium pyruvate and 40 μg/ml 
gentamycin (Flow laboratories, Rockwell, MD) in a 5% CO2 
humidiﬁ  ed atmosphere at 37 °C. Cells (1–2 × 105/mL) were 
cultured in complete RPMI 1640 medium at 37 °C in the 
absence or presence of various concentrations of compounds 
(10−7–10−4M). After various periods of incubation, cells were 
collected, washed twice, and living cells (with diameters 
ranging from 7 to 14 μm) were counted in a cell Coulter 
Counter ZM equipped with a Coultronic 256 channelizer 
(Coulter/Beckman). Maturation of cells toward the 
monocyte/macrophage or granulocytic pathway was deter-
mined according to the change in morphology assessed by 
staining cytocentrifuged cells (using a Shandon 3 Cytospin, 
Thermo Electron) with the Hemacolor kit from Merck and 
light microscope examination, and quantiﬁ  cation of several 
phenotypic markers characteristic of cell maturation into 
macrophages (CD11b) or granulocytes (CD15, CD13, CD44) 
as assessed by ﬂ  ow cytometry analysis (see below).
Flow cytometry analysis of cell 
differentiation, apoptosis and death
Intact cells were immunostained with Abs directed against 
CD11b, CD13, CD15, CD44 as described (Bauvois et al 
2002). Analysis was performed in a FACS ﬂ  ow cytometer 
analyzer (Coulter-Beckman, Luminy, France). Values are 
given as percentages of positive cells and antigen relative 
density per cell (obtained by subtracting the peak channel 
number of the negative control from the peak channel 
number of the corresponding experimental sample). 
Apoptosis was determined by the binding of Annexin-V-
FITC to phosphatidylserine exposed to the cell membrane, 
used in conjunction with propidium iodide (PI), to evaluate 
subpopulations of cells along the apoptotic pathway according 
to the manufacturer’s instructions.
Reverse transcriptase-polymerase chain 
reaction (RT-PCR)
RNA extraction from treated cells and cDNA synthesis 
were conducted as described (Bauvois et al 2002). Speciﬁ  c 
human primers for human β2-microglobulin, MMP9, TNF-
α, and vascular endothelial growth factor (VEGF), chosen 
according to published sequences (Westphal et al 2000; Bau-
vois et al 2002; Stordeur et al 2002; Parks et al 2004) were 
as follows: β2-microglobulin (165 bp), 5'-CAT CCA GCG 
TAC TCC AAA GA-3' (forward) and 5'-GAC AAGT CTG 
AAT GCT CCA C-3' (reverse); MMP-9 (296 bp), 5'- GGA 
GAC CTG AGA ACC AAT CTC-3' (forward) and 5'-TCC 
AAT AGG TGA TGT TGT CGT-3' (reverse); VEGF (204 
bp), 5'- ACA TCT TCC AGG AGT ACC CTG ATG AG-3' 
(forward) and 5’- GCA TTC ACA TTT GTT GTG CTG T-3' 
(reverse); TNF-α (406 bp), 5'-ACC ATG AGC ACT GAA 
AGC AT-3' (forward) and 5'-AGA TGA GGT ACA GGC 
CCT CT-3' (reverse). The PCR products were visualized 
by electrophoresis in 2% agarose gel containing 0.2 μg/ml 
ethidium bromide. The β2-microglobulin gene was used to 
normalize the PCR products. The NIH Image 1.63 software 
was used for the analysis of the bands after acquisition in an 
Appligen densitometer (Oncor).
Measurement of MMP-9 gelatinolytic 
activity by zymography
Analysis of MMP-9 activity was carried out in 7.5% (w/v) 
SDS-polyacrylamide gels containing 0.2% gelatin (w/v) as 
described elsewhere (Bauvois et al 2002). Equal amounts 
of culture media (20 μl) were applied to the gel in Laemmli 
sample buffer lacking β-mercaptoethanol. Gelatinolytic 
activities of pro-MMP-9 (92 kDa) and mature MMP-9 
(82 kDa) were detected as transparent bands on the back-
ground of Eza-blue stained gelatin. The bands were acquired 
with an Appligen densitometer (Oncor).
Enzyme-linked immunosorbent assays
The culture supernatant fractions from cells (105 cells/mL) 
cultured for 3 days in the absence or presence of thiosulﬁ  nates 
were harvested under sterile conditions and frozen before 
MMP-9, VEGF, and TNF-α contents were determined 
using commercial ELISA kits provided by R&D (Abingdon, 
UK). Controls included FCS-supplemented RPMI 1640 
medium alone incubated under the same conditions. The 
concentrations were calculated after substraction of the 
control values. Detection level was 10 pg/mL for TNF-α 
and VEGF, and 1 ng/mL for MMP-9.
Statistical analysis
Values are represented as means ± SD of n independent 
experiments.
Results
Pr2TS and Me2TS induce growth arrest 
of AML cell lines
The antiproliferative potential of All2TS, Pr2TS and Me2TS 
and their related sulﬁ  des (DADS, DAS, DMDS, DPDS) were 
ﬁ  rst evaluated in the U937 cell line. Cells were cultured 3 days Biologics: Targets & Therapy 2008:2(4) 888
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in the absence or in the presence of increasing concentrations 
of the compounds (10−7–10−3 M). The growth of U937 cells 
was inhibited by Pr2TS (Figure 2A) and Me2TS (Figure 2B) 
with IC50 values (half-maximal inhibitory concentrations) 
of 2 μM, whereas their related sulﬁ  des in the same range of 
concentration did not alter cell growth (Figure 2C). All2TS, 
DAS, and DADS did not affect cell growth (Figure 2D) and 
HPLC analysis showed that All2TS was totally degraded 
upon 24 h cell culture. Kinetic studies indicated also a time-
dependent inhibitory effect of Pr2TS and Me2TS on cell 
growth (Figure 3A). NB4 and MonoMac-6 cell lines were 
also sensitive to Pr2TS and Me2TS (Figure 3B).
Pr2TS and Me2TS do not induce U937 
cell death
We next questioned whether the inhibition of U937 cell growth 
by Pr2TS and Me2TS was associated with cytotoxicity. The 
criteria for cell death, measured by Cell Coulter analysis, was 
based on the number of necrotic cells with diameters  7 μm 
(reﬂ  ecting cell shrinkage), and Figure 2A and B shows that 
Pr2TS and Me2TS tested did not induce a marked cytotoxic 
effect. It was next investigated whether decreased growth 
was related to apoptosis. To this end, we analyzed the surface 
binding of Annexin V, known as an early marker of apop-
tosis (Martin et al 1995) with simultaneous PI staining for 
necrotic cells. Figure 4 shows a representative experiment in 
which U937 cells were cultured for 3 days in the absence or 
presence of Pr2TS, Me2TS (5 μM) in comparison to the pro-
apoptotic agent nigericin as a positive control. In contrast to 
untreated U937 cells (Figure 4A), cells treated with nigericin 
were strongly positive for Annexin V (L4 = 34%, Figure 4B, 
apoptotic cells) and for both Annexin V and PI (L2 = 40%, 
Figure 4B, secondary necrotic cells). U937 cells treated with 
Pr2TS or Me2TS were found weakly positive for Annexin V 
(L4   14%), and for both Annexin V and PI (L2   11%, 
Figure 4B and 4C). Moreover, using Apo 2.7 antibody which 
reacts with a mitochondrial protein exposed on cells undergo-
ing apoptosis, we conﬁ  rmed that Pr2TS and Me2TS did not 
induce U937 cell apoptosis (data not shown).
Pr2TS and Me2TS induce differentiation 
of AML cells towards macrophages
The capacity of U937 cells to undergo macrophage 
maturation was further measured by examining the 
Figure 2 Dose-dependent effects of thiosulﬁ  nates and sulﬁ  des on U937 cell proliferation. Cells (105/mL) were cultured for 3 days in the absence (control) or in the presence 
of increasing concentrations (10−7−10−4M) of Pr2TS (A), Me2TS (B), DPDS (C), DMDS (C), All2TS (D), DAS (D) or DADS (D). After 3 days, living cells and necrotic cells 
were counted with a cell Coulter as described in Methods. Results are expressed as % of untreated cells (100% = 9 × 105 cells/mL ± 105). Data represent the means of 
2–5 independent determinations ± SD.
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modulation of expression of the CD11b antigen and the 
change in morphology of stimulated cells. Enhanced CD11b 
expression has been associated with monocyte/macrophage 
differentiation (Kim et al 1991). At day 4, the block in 
growth of Pr2TS- and Me2TS-treated U937 cells was 
correlated with a marked enhanced expression of CD11b 
as compared to untreated cells (Figure 5A). In parallel, a 
change in morphology (increase in cell size, decrease in the 
nuclear/cytoplasmic ratio and apparition of vacuolisation) 
consistent with macrophage differentiation was observed 
in cells exposed to Pr2TS and Me2TS when compared to 
untreated cells (Figure 5B). As positive control, PMA-treated 
cells presented morphological features of cell maturation and 
these modiﬁ  cations were accompanied by the up-regulation 
of CD11b (Figure 5A and B). Similarly, Pr2TS and Me2TS 
induced a marked shift towards a macrophage morphology 
associated with the enhanced expression of CD11b in the 
other cell lines (data not shown).
Pr2TS and Me2TS do not induce 
differentiation of HL-60 and NB4 
cells towards granulocytes
Additionally, we investigated whether Pr2TS and Me2TS 
could also induce differentiation part of these cells 
towards granulocytes. Myeloblastic cell lines such as 
NB4 and HL-60 can be induced to differentiate into 
granulocyte-like cells by all-trans retinoic acid (ATRA) 
(Collins 1987; Khanna-Gupta  et al 1994). Previously 
described changes in antigen expression by ATRA-treated 
cells include the increase of CD15 in HL-60 and NB4 cells 
(Lanotte et al 1991; Trayner et al 1998; Barber et al 2008) 
and the down-regulation of CD13 and CD44 in HL-60 cells 
(Trayner et al 1998; Barber et al 2008). Although to a lower 
degree, Pr2TS and Me2TS (5 μM) were capable of inhibiting 
HL-60 cell growth (40% inhibition at day 5). Following 
treatment with 10 μM ATRA for 5 days, HL-60 and NB4 
cells presented morphologic features of granulocytes (data 
not shown) associated with the increased expression of CD15 
(HL-60 and NB4) and the decreased expression of CD13 
and CD44 (HL-60) (Table 1). In contrast, cells treated with 
Pr2TS or Me2TS (5 μM) did not have any effect on CD13, 
CD15 and CD44 expression (Table 1). Together, our results 
indicate that Pr2TS and Me2TS do not induce AML cells to 
mature along the granulocytic lineage.
Inhibitory effects of Pr2TS and Me2TS 
on MMP-9 and TNF-α release by U937 
and NB4 cells
As assessed by ELISA and zymography analyses of the 
conditioned media from day 3-cultured cells, very low 
amounts of matrix metalloproteinase-9 (MMP-9, 92 kDa) 
were produced by U937 cells and NB4 cells ( 10 ng/mL). 
In parallel, no change in MMP-9 mRNA expression was 
observed to Pr2TS or Me2TS (from 24 to 72 h, data not 
shown). As described previously (Watanabe et al 1993), 
exposure to PMA markedly increased the levels of released 
MMP-9 as assessed by its gelatinolytic activity (about 10-fold 
increase, Figure 6A). Addition of Pr2TS or Me2TS (5 μM) to 
the culture medium resulted in a reduction of released MMP-9 
activity from PMA-activated cells (Figure 6A). ELISA data 
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Figure 3 Time-dependent effects of Pr2TS and Me2TS on U937 cell proliferation; 
comparative effects with NB4 and MonoMac-6 cells. (A) U937 cells (105/mL) were 
cultured in the absence or presence of 5 μM Pr2TS or Me2TS for 1 to 4 days. Results 
are expressed as percentage of untreated cells (100% = 9 × 105 cells/mL ± 105). Data 
represent the means of 2 to 6 independent determinations ± SD. (B) U937, NB4 and 
MonoMac-6 cells (105/mL) were cultured in the absence or presence of 5 μM Pr2TS 
or Me2TS for 3 days (U937, NB4, MonoMac-6). Results are expressed as percentage 
of untreated cells. (100% = 9 × 105 cells/mL ± 105 for U937 and MonoMac-6; 100% = 
8 × 105 cells/mL ± 105 for NB4). Data represent the means of n independent determina-
tions ± SD (n = 7 to 13 for U937; n = 5 to 6 for MonoMac-6; n = 3 to 6 for NB4).Biologics: Targets & Therapy 2008:2(4) 890
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Figure 4 Representative histograms showing ﬂ  ow cytometry analysis of Annexin V-FITC/PI stained U937 cells. Cells were cultured in the absence (A) or presence of 10 μM 
nigericin (proapoptotic agent, positive control) (B), 5 μM Pr2TS (C) or 5 μM Me2TS (D) on U937 cells for 3 days. Results are expressed as log PI ﬂ  uorescence intensity (y-axis) 
vs log Annexin V ﬂ  uorescence intensity (x-axis).
Abbreviations: L1, necrotic cells; L2, secondary necrotic cells; L3, healthy cells; L4, apoptotic cells; PI, propidium iodide.
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conﬁ  rmed that diminished MMP-9 gelatinolytic activity 
resulted from the decrease in MMP-9 protein (Figure 6B). 
PCR analysis was used to examine the steady-state MMP-9 
mRNA alteration before and after Pr2TS or Me2TS treatment. 
As shown in Figure 6C, Pr2TS or Me2TS did not alter the 
apparent levels of MMP-9 transcripts in PMA-activated 
cells treated for 24 h. In parallel, the amounts of TNF-α 
protein released from PMA-activated cells were also strongly 
diminished following Pr2TS or Me2TS treatment (Figure 7A) 
while the mRNA contents of TNF-α were slightly affected 
by Pr2TS or Me2TS at 24 h (Figure 7B), TNF-α mRNA/β2 
mRNA ratios being decreased by 25% for Pr2TS and 49% 
for Me2TS. In both cell types, vascular endothelial growth 
factor (VEGF) protein and mRNA levels remained almost 
unchanged by Pr2TS and Me2TS (Figure 7A and B).
Discussion
Our present study provides new information about the 
inﬂ  uence of thiosulﬁ  nates (TS) in human malignant myeloid 
cell lines which are representative of acute myeloid leukemia 
cells accordingly to the French-American-British (FAB) 
classiﬁ  cation. These are HL-60 (FAB M2), NB4 (FAB M3), 
U937 and MonoMac-6 (FAB M5) cell lines.
We ﬁ  rst describe the ability of Pr2TS and Me2TS to 
inhibit in a concentration- and time-dependent manner the 
growth of leukemic cells in vitro. The comparison with 
their sulﬁ  de analogues (DPDS and DMDS) which do not 
show any inﬂ  uence on cell proliferation in the same range 
of concentration (up to 100 μM), suggests that the sulfoxide 
group plays a critical role in TS activity. In contrast, All2TS 
as well as its sulﬁ  de analogues DAS and DADS did not 
affect cell growth, and such lack of effect of All2TS was 
associated to its decomposition to sulﬁ  des as previously 
reported (Amagase 2006). In contrast to our study, allyl 
sulﬁ  des (from 10 to 100 μM) have been reported to reduce 
in culture and in vivo the growth rate of human cancer cell 
lines derived from solid tumors (Sundaram et al 1996b; 
Hosono et al 2005; Xiao et al 2005, 2006; Milner 2006), 
possibly by regulating factors involved in cellular prolifera-
tion such as NF-κB (Pinto et al 2001) or p21 (Milner 2006). 
Further research is required to clarify the mechanisms of 
inhibition of AML cell proliferation by Pr2TS and Me2TS. 
The mitogen-activated protein kinase (MAPK) pathway 
that proceeds from Ras, and its downstream effector Raf 
to MAPK kinase (MEK) and extracellular signal activated 
kinase (ERK), links various extracellular stimuli to prolif-
eration, differentiation and survival. The MAPK signaling 
is constitutively active in blast cells of the majority of AML 
patients, and its blockade by selective small molecules 
inhibitors impairs leukemic cell proliferation (Milella et al 
2001; Platanias 2003). It has also to be pointed out that the 
level of NF-κB is high in AML (Baumgartner et al 2002). 
Whether Pr2TS and Me2TS block NF-κB or MAPK activities 
is currently under investigation.
Organosulfur compounds may exhibit proapoptotic 
actions on various models of human cancers (Sundaram 
et al 1996a; Kwon et al 2002; Xiao et al 2003, 2005; 
Herman-Antosiewicz et al 2004; Hosono et al 2005). 
However, our experiments clearly indicate that Pr2TS and 
Me2TS do not induce cell apoptosis. Instead, the block in 
AML cell growth by Pr2TS and Me2TS is accompanied by 
differentiation of cells toward the monocyte/macrophage 
pathway as assessed by phenotypic and morphologic features. 
TNF-α is an autocrine stimulus for supporting macrophage 
differentiation (De Benedetti et al 1990; Kamijo et al 1990). 
By ELISA analysis, we showed that unstimulated cells secreted 
very low levels of TNF-α (2 ± 0.17 pg/mL/105cells) which 
were not altered with Pr2TS (1.81 ± 0.17 pg/mL/105 cells) 
Table 1 Effects of ATRA, Pr2TS and Me2TS on the expression of CD13, CD15 and CD44 on HL-60 and NB4 cells
Antibody antigen Granulocyte 
expression
Percent of positive cells (relative density)
Control ATRA Pr2TS Me2TS
1) on HL-60
CD13 ↓ 82 (30) 74 (17) 89 (36) 87 (36)
CD15 ↑ 67 (35) 69 (84) 62 (40) 62 (27)
CD44 ↓ 48 (168) 42 (28) 47 (169) 48 (197)
2) on NB4
CD15 ↑ 55 (17) 82 (98) 58 (26) 39 (16)
Notes: Cells cultured for 5 days in the absence (control) or presence of ATRA (10 μM), Pr2TS or Me2TS (5 μM) were assayed for expression of surface CD13, CD15 and 
CD44.   Values are given as % of CD positive cells and CD relative density per cell (in brackets), up-regulation of CD15 (Lanotte et al 1991;   Trayner et al 1998; Barber et al 2008); 
down-regulation of CD13 and CD44 (Trayner et al 1998; Barber et al 2008).Biologics: Targets & Therapy 2008:2(4) 892
Merhi et al
A
B
C
- - Pr2TS Me2TS Pr2TS Me2TS
-- Pr2TS Me2TS Pr2TS Me2TS
NB4
U937 NB4
U937
92 kDa
MMP-9
β2 microglobulin
24.1
±1.6 ±0.1 ±1.3 ±1.1 ±0.6 ±0.1
16.4 20.4 10.5 7.4 18.5 ELISA
ng/mL/106 Cells
▼
►
►
►
▼▼▼ ▼ ▼
Figure 6 Effects of Pr2TS and Me2TS on MMP-9 expression in PMA-activated U937 and NB4 cells. U937 and NB4 cells (105/mL) activated with 1 ng/mL PMA, were cultured 
for 24 or 72 h in the absence or presence of Pr2TS and Me2TS (5 μM). (A) Analysis of gelatinolytic activity in the culture media of 72 h-treated cells. The enzymatic activity of 
MMP-9 was analyzed using zymography performed with equal amounts of protein loaded. Gelatinolytic activities are detected as clear bands in the gel. (B) MMP-9 concentra-
tions in the culture media of 72 h-treated cells were quantiﬁ  ed by ELISA. Values are expressed as ng/mL/105 cells (mean of 2 determinations ± SD). (C) RT-PCR analysis of 
MMP-9 and β2-microglobulin transcripts in 24 h-treated cells.
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Figure 7 Effects of Pr2TS and Me2TS on VEGF and TNF-α expression in PMA-activated U937 and NB4 cells. U937 and NB4 cells (105/mL) activated with 1 ng/mL PMA, were 
cultured for 24 or 72 h in the absence or presence of Pr2TS and Me2TS (5 μM). (A) ELISA analyses of VEGF and TNF-α concentrations in culture media of 72 h-treated cells. 
Values are expressed as pg/mL/105 cells. (B) RT-PCR analysis of VEGF, TNF-α and β2-microglobulin transcripts in 24 h-treated cells.Biologics: Targets & Therapy 2008:2(4) 893
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or Me2TS (1.94 ± 0.19 pg/mL/105 cells ) thus indicating 
that endogenous TNF-α is not implicated in Pr2TS-/
Me2TS-mediated cell maturation. The molecular mechanisms 
involved in regulating the balance between proliferation 
and differentiation in the monocytic/macrophage lineage 
remain poorly understood. The retinoblastoma gene product 
(Bergh et al 1999), interferon regulatory factors (Manzella 
et al 1999; Lu et al 2001) and the Ets repressor PE-1/METS 
(Sawka-Verhelle et al 2004) have been reported to play a 
critical role in the monocytic commitment. Whether Pr2TS 
and Me2TS could inﬂ  uence the activity of these factors 
remains to be determined. Differentiation therapy with 
retinoic acid plays an important role in treating acute pro-
myelocytic leukemia (Jurcic et al 2007). Our data suggests 
that the addition of speciﬁ  c agents such as Pr2TS or Me2TS 
to differentiation therapy could be explored.
AML is an hematological disorder which is associated 
with an increased angiogenesis which disappears if 
complete hematological remission is achieved (Rajkumar 
et al 2002; Ribatti et al 2004; Longo et al 2007). Because 
of its capacities to degrade components of the extracellular 
matrix and angiogenic factors, MMP-9 can play a role in 
cancer progression by affecting tumor angiogenesis, tumor 
growth and/or metastasis (Opdenakker et al 2003; Parks et al 
2004; Deryugina et al 2006). MMP-9 is synthesized as a 
preproenzyme, secreted as a proform (92 kDa) and processed 
in a 82 kDa form resulting from the proteolytic removal of a 
fragment of its N-terminal domain (Opdenakker et al 2003). 
AML leukemic cells express and release 92 kDa MMP-9 
(Klein et al 2004). We show here that Pr2TS and Me2TS 
decrease MMP-9 production by activated U937 and NB4 
cells. At the mRNA level, no early regulation was detectable 
indicating a post-transcriptional event. In connection with 
organosulfurs, Meyer and colleagues (2004) showed that 
DADS inhibit the secretion of MMP-9 by HUVEC cells 
while not affecting MMP-9 mRNA levels. Besides MMP-9, 
VEGF and TNF-α are important partners of angiogenesis 
(Kini et al 2001; Thomas et al 2001; Ribatti et al 2004). 
In addition to its angiogenic properties, VEGF may serve 
as an autocrine/paracrine growth factor for leukemia cells 
(Fiedler et al 1997; Rajkumar et al 2002). TNF-α stimulates 
various NF-κB target genes that modulate cell survival and 
proliferation, tumor metastasis and angiogenesis (Braun 
et al 2006; Cilloni et al 2007). Among NF-κB target genes 
are MMP-9 and Bcl-2 whose proteins levels are enhanced 
in AML (Mayo et al 2000; Braun et al 2006). A previous 
study showed that DADS inhibited the production of 
IL-1β and TNF-α by blood monocytes stimulated with 
lipopolysaccharide (Keiss et al 2003). Our results indicate 
that Pr2TS and Me2TS inhibit TNF-α production by U937 and 
NB4 cells at the post-transcriptional level, without affecting 
VEGF expression. Whether Pr2TS and Me2TS inhibit the 
synthesis or the release of MMP-9 and TNF-α remains to 
be determined.
In conclusion, this work provides ﬁ  rst evidence that 
Pr2TS and Me2TS may exhibit antitumor activity against 
AML cell lines by affecting cell growth, differentiation 
and secretion of factors involved in tumoral processes. 
Our data suggest that these TS are promising compounds 
for improving AML therapy. A very recent study has 
demonstrated selective apoptosis of childhood pre-B acute 
lymphoblastic leukemia cells in vitro by DATS and ajoene 
(Hodge et al 2008) emphasizing the potential of Allium for 
possible treatment of human leukemias. Further studies are 
required to validate our observations with these TS in AML 
patients’ cells.
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